In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and in some cases overlapping with—the frameworks for drugs and biologics.
Jonathan B. Roses, an attorney with Wolf Greenfield, examines how medical devices are regulated nationally and advises innovators how to protect their intellectual property effectively in this article. Read more here.
